Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

The −174 G/C polymorphism of the interleukin-6 gene promoter and essential hypertension in an elderly Italian population

Journal of Human Hypertension volume 16, pages 637–640 (2002)Cite this article

Abstract

Several studies have proposed a relationship between blood pressure and inflammation. Interleukin-6 (IL-6) is a multifunctional cytokine involved in inflammation and tissue injury and potentially influencing blood pressure. Recently, a common polymorphism of the IL-6 gene, associated with differences in the transcription rate of the protein, has been described. The aim of this study was to investigate a possible association between genetic variations of the −174GC polymorphism of the IL-6 gene promoter and hypertension in humans. IL-6 gene promoter polymorphism was evaluated by polymerase chain reaction followed by restriction enzyme analysis in 210 elderly Italian patients affected by essential hypertension (EH) and 177 age- and sex-matched controls. The distribution of IL-6 genotypes was 85 GG, 88 GC, 37 CC in the hypertensive patients and 65 GG, 73 GC, 39 CC in the control subjects. In this elderly cohort, no statistically significant association was found between the two groups (P = 0.45 for GG homozygous, P = 0.89 for GC heterozygous and P = 0.27 for CC homozygous). In conclusion the −174 GC polymorphism of the IL-6 gene promoter is not a marker for EH in this sample of elderly Italians.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Similar content being viewed by others

References

  1. Taylor WR . Hypertensive vascular disease and inflammation: mechanical and humoral mechanisms Curr Hypertens Rep 1999 1: 96–101

    Article  CAS  PubMed  Google Scholar 

  2. Intengan HD et al. Vascular remodeling in hypertension: roles of apoptosis, inflammation, and fibrosis Hypertension 2001 38: 581–587

    Article  CAS  PubMed  Google Scholar 

  3. Dzielak DJ . The immune system and hypertension Hypertension 1992 19: 36–44

    Article  Google Scholar 

  4. Fu ML . Do immune system changes have a role in hypertension? J Hypertens 1995 13: 1259–1265

    Article  CAS  PubMed  Google Scholar 

  5. Peeters AC et al. Pro-inflammatory cytokines inpatients with essential hypertension Eur J Clin Invest 2001 31: 31–36

    Article  CAS  PubMed  Google Scholar 

  6. Chen CM et al. Elevation of plasma immunoglobulin A in the spontaneously hypertensive rat Hypertension 1993 21: 731–738

    Article  CAS  PubMed  Google Scholar 

  7. Heinrich PC et al. Interleukin-6 and the acute phase response Biochem J 1990 265: 621–636

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  8. Heinrich PC et al. Interleukin-6 and the acute phase response Biochem J 1990 265: 621–636

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  9. Biasucci LM et al. Elevated levels of interleukin-6 in unstable angina Circulation 1996 94: 847–874

    Article  Google Scholar 

  10. Ridker PM et al. Plasma concentration of interleukin-6 and the risk of future myocardial infarction among apparently healthy men Circulation 2000 101: 1767–1772

    Article  CAS  PubMed  Google Scholar 

  11. Dalmon J et al. The human beta fibrinogen promoter contains a hepatocyte nuclear factor 1-dependent interleukin-6-responsive element Mol Cell Biol 1993 13: 1183–1193

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  12. Lowe GDO et al. Coagulation, fibrinolysis and cardiovascular disease Fibrinolysis and Proteolysis 1999 13: 91–98

    Article  CAS  Google Scholar 

  13. Woodward M et al. Associations of blood rheology and interleukin-6 with cardiovascular risk factors and prevalent cardiovascular disease Br J Haematol 1999 104: 246–257

    Article  CAS  PubMed  Google Scholar 

  14. Takano M et al. Interleukin-6 as a mediator responsible for inflammation-induced increase in plasma angiotensinogen Biochem Pharmacol 1993 45: 201–206

    CAS  PubMed  Google Scholar 

  15. Soden M et al. Angiotensinogen: an acute-phase protein? Hypertension 1994 23: 126–130

    Article  Google Scholar 

  16. Kranzhofer R et al. Angiotensin induces inflammatory activation of human vascular smooth muscle cells Arterioscler Thromb Vasc Biol 1999 19: 1623–1629

    Article  CAS  PubMed  Google Scholar 

  17. Yudkin JS et al. C-reactive protein in healthy subjects: associations with obesity, insulin resistance, and endothelial dysfunction: a potential role for cytokines originating from adipose tissue? Arterioscler Thromb Vasc Biol 1999 19: 972–978

    Article  CAS  PubMed  Google Scholar 

  18. Mohamed-Ali V et al. Subcutaneous adipose tissue releases interleukin-6, but not tumor necrosis factor-alpha, in vivo J Clin Endocrinol Metab 1997 82: 4196–4200

    CAS  PubMed  Google Scholar 

  19. Greenwel P et al. Induction of an acute phase response in rats stimulates the expression of alpha 1(I) procollagen messenger ribonucleic acid in their livers.Possible role of interleukin-6 Lab Invest 1995 72: 83–91

    CAS  PubMed  Google Scholar 

  20. Silacci P et al. Interleukin (IL)-6 and its soluble receptor induced TIMP-1 expression in synoviocytes and chondrocytes, and block IL-1-induced collagenolytic activity Biol Chem 1998 273: 13625–13629

    Article  CAS  Google Scholar 

  21. Fishman D et al. The effect of novel polymorphism in the interleukin-6 (IL-6) gene on IL-6 transcription and plasma IL-6 levels, and an association with systemic onset juvenile chronic arthritis J Clin Invest 1998 102: 1369–1376

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  22. Terry CF et al. Cooperative influence of genetic polymorphisms on interleukin-6 transcriptional regulation J Biol Chem 2000 275: 18138–18144

    Article  CAS  PubMed  Google Scholar 

  23. Fernandez-Real JM et al. Interleukin-6 gene polymorphism and lipid abnormalities in healthy subjects J Clin Endocrinol Metab 2000 85: 1334–1339

    Article  CAS  PubMed  Google Scholar 

  24. Rauramaa R et al. Stromelysin-1 and interleukin-6 gene promoter polymorphisms are determinantsof asymptomatic carotid artery atherosclerosis Arterioscler Thromb Vasc Biol 2000 20: 2657–2662

    Article  CAS  PubMed  Google Scholar 

  25. Rus HG et al. Interleukin-6 and interleukin-8 protein and gene expression in human arterial atherosclerotic wall Atherosclerosis 1996 127: 263–271

    Article  CAS  PubMed  Google Scholar 

  26. Sukovich DA et al. Expression of interleukin-6 in atherosclerotic lesions of male ApoE-knockout mice: inhibition by 17βestradiol Arterioscler Thromb Vasc Biol 1998 18: 1498–1505

    Article  CAS  PubMed  Google Scholar 

  27. Jones KG et al. Interleukin-6 (IL-6) and the prognosis of abdominal aortic aneurysms Circulation 2001 103: 2260–2265

    Article  CAS  PubMed  Google Scholar 

  28. Humphries SE et al. The interleukin-6-174 G/C promoter polymorphism is associated with risk of coronary heart disease and systolic blood pressure in healthy men Eur Heart J 2001 22: 2243–2252

    Article  CAS  PubMed  Google Scholar 

  29. Nakajima T et al. Allelic variants in the interleukin-6 gene and essential hypertension in Japanese women Genes Immun 1999 1: 115–119

    Article  CAS  PubMed  Google Scholar 

  30. Van Snick J . Interleukin-6: an overview Ann Rev Immunol 1990 8: 253–278

    Article  CAS  Google Scholar 

  31. Papanicolau DA et al. The pathophysiologic roles of interleukin-6 in human disease Ann Intern Med 1998 128: 127–137

    Article  Google Scholar 

  32. Marian AJ . On genetics, inflammation, and abdominal aortic aneurysm Circulation 2001 103: 2222–2224

    Article  CAS  PubMed  Google Scholar 

  33. Bowcock AM et al. The human ‘interferon-beta 2/hepatocyte stimulating factor/interleukin-6’ gene: DNA polymorphism studies and localization to chromosome 7p21 Genomics 1988 3: 8–16

    Article  CAS  PubMed  Google Scholar 

  34. Bagli M et al. Association between an interleukin-6 promoter and 3′ flanking region haplotype and reduced Alzheimer's disease risk in a German population Neurosci Lett 2000 283: 109–112

    Article  CAS  PubMed  Google Scholar 

  35. Yamashita J et al. Opposite regulation of Gax homeobox expression by angiotensin II and C-type natriuretic peptide Hypertension 1997 29: 381–387

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Laboratory of Vascular Biology and Genetics, A. Gemelli University Hospital, Università Cattolica del Sacro Cuore School of Medicine, Rome, Italy

    R Pola, A Flex, E Gaetani & P Pola

  2. Department of Geriatric Medicine, Università Cattolica del Sacro Cuore School of Medicine, Rome, Italy

    R Pola & R Bernabei

  3. Department of Medicine, Università Cattolica del Sacro Cuore School of Medicine, Rome, Italy

    A Flex, E Gaetani & P Pola

Authors
  1. R Pola
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. A Flex
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. E Gaetani
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. P Pola
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. R Bernabei
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to P Pola.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Pola, R., Flex, A., Gaetani, E. et al. The −174 G/C polymorphism of the interleukin-6 gene promoter and essential hypertension in an elderly Italian population. J Hum Hypertens 16, 637–640 (2002). https://doi.org/10.1038/sj.jhh.1001462

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.jhh.1001462

Keywords

This article is cited by

Search

Advanced search

Quick links